So Tony, with JP stating, as many times before, that NEU is not set up for manufacture and distribution and they have no intention of selling off bits, you are saying that we will have to have been taken over or entered a licensing agreement for all indications , excluding Retts and Fragile X which are with Acadia, before submitting P3 results with application to FDA for marketing the drug within the U.S.A. in 2nd half of 2026 all going well?
NEU Price at posting:
$12.97 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)